GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the cytoplasmic domain of flha in monomeric form

Analyse Crystal structure of the cytoplasmic domain of flha in monomeric form in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6CH1
Type
protein
Length
332 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Flagellar biosynthesis protein flha
UniProt
P40729
Pockets
4 · best druggability 0.45

Structure

x-ray diffraction · 1 distinct chain · 48% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AFlagellar biosynthesis protein flhaprotein33248% helix, 18% strandP40729

Ligands and binding sites

  • EDO · 1,2-ethanediol · additive · 9 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11460.450.7628EDO
21440.440.7622empty
3720.390.7820EDO
4640.340.7614empty

Compared structures

  • 6CH1 · Crystal structure of the cytoplasmic domain of FlhA in monomeric form · the same entry in another collection · chain A against A, TM-score 1.00
  • P40729 · AlphaFold monomer V2.0 prediction for flagellar biosynthesis protein flha (P40729) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.